Immediate results of carotid endarterectomy in patients receiving statin therapy

封面

如何引用文章

全文:

详细

Given the retrospective analysis of the immediate result of carotid endarterectomy in patients with atherosclerotic hemodynamically significant unilateral lesion of the internal carotid artery on statins therapy. 262 carotid endarterectomy in 262 patients are executed. The postoperative period averaged 7.8 days, survival after surgical treatment of 98.86%. The initial condition of the carotid arteries was determined data by duplex scanning, the presence of risk factors and level of lipid profile that have a statistically significant influence on the development of complications in patients receiving statins therapy (p<0.05). Each risk factor did not have a statistically significant impact, however the presence of three or more factors reliably more often aggravated the course of atherosclerosis and increased the incidence of complications (p=0.04). Defined the reliable interrelation of dependence of a lipid profile level (a cholesterol and low density lipoproteins (LDL)) and weight of a course of initial atherosclerotic changes. The maximal values of cholesterol level 5.39±1.13 mmol/l were determined in patients with stenosis of internal carotid artery from 70 to 89% (р=0.05). In all cases of a stenosis of 90% there was increase in level of triglycerides to 1.75±1.05 mmol/l (р=0.05). LDL in all patients registered above the recommended values of 3.45±1.19 mmol/l. However, it is worth noting against the background of statin therapy, the level of high density lipoproteins in the average values did not decrease below 1.46±0.46 mmol/l (p=0.05). Statin therapy has a different degree of influence on the achievement of recommended values of lipid metabolism and the development of complications. In one case (0.38%) there were recorded stroke, transient ischemic attack and myocardial infarction. So effective is the use of synthetic statins III and IV generations: atorvastatin and rosuvastatin. Statin therapy in the preoperative period and continued after surgical important for achieve the surgery to prevent complications. Correction risk factors, such as hypertension, diabetes, smoking, dyslipidemia and other, helps to improve treatment outcomes.

作者简介

A. Zybin

Russian Medical Academy of Continuous Professional Education

编辑信件的主要联系方式.
Email: meda83@mail.ru
俄罗斯联邦, 2/1, building 1, Barrikadnaja str., Moscow, 125993

I. Timina

A.V. Vishnevsky Institute of Surgery

Email: meda83@mail.ru

д.м.н., проф., заведующая отделением

俄罗斯联邦, 27, Bol'shaja Serpuhovskaja str., Moscow, 117997

A. Pokrovsky

Russian Medical Academy of Continuous Professional Education; A.V. Vishnevsky Institute of Surgery

Email: meda83@mail.ru

академик РАН, проф., заведующий отделением, заведующий кафедрой

俄罗斯联邦, 2/1, building 1, Barrikadnaja str., Moscow, 125993; 27, Bol'shaja Serpuhovskaja str., Moscow, 117997

A. Harazov

Russian Medical Academy of Continuous Professional Education; A.V. Vishnevsky Institute of Surgery

Email: meda83@mail.ru

к.м.н., старший научный сотрудник, зав. учебной частью

俄罗斯联邦, 2/1, building 1, Barrikadnaja str., Moscow, 125993; 27, Bol'shaja Serpuhovskaja str., Moscow, 117997

参考

  1. Zureik M, Ducimetiere P, Touboul PJ, Courbon D, Bonithon-Kopp C, Berr C et al. Common carotid intima-media thickness predicts occurrence of carotid atherosclerotic plaques: longitudinal results from the Aging Vascular Study (EVA) study. Arterioscler Thromb Vasc Biol. 2000; 20: 1622-9.
  2. Amarenco P, Labreuche J, Lavallee P, Touboul PJ. Statins in stroke prevention and carotid atherosclerosis: systematic review and up-todate meta-analysis. Stroke. 2004; 35: 2902-9.
  3. Sillesen H, Amarenco P, Hennerici MG, Callahan A, Goldstein LB, Zivin J et al. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2008; 39: 3297-302.
  4. Espeland MA, O’Leary DH, Terry JG, Morgan T, Evans G, Mudra H. Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors. Curr Control Trials Cardiovasc Med. 2005; 6 (3): 1-6.
  5. Dobs AS, Nieto FJ, Szklo M. Risk factors for popliteal and carotid wall thicknesses in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 1999; 150: 1055-67.
  6. AbuRahma AF, Srivastava M, Stone PA. Effects of Statins on Early and Late Clinical Outcomes of Carotid Endarterectomy and the Rate of Post-Carotid Endarterectomy Restenosis. Journal of Vascular Surgery. 2015; 62 (6): 1678-9.
  7. Kiortsis DN, Filippatos TD, Mikhailidis DP, Elisaf MS, Liberopoulos EN. Statin-associated adverse effects beyond muscle and liver toxicity. Atherosclerosis. 2007; 195: 7-16.
  8. Durazzo AE, Machado FS, Ikeoka DT. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg. 2004; 39: 967-76.
  9. Schouten O, Kertai MD, Bax JJ. Safety of perioperative statin use in high risk patients undergoing major vascular surgery. Am J Cardiol. 2005; 95: 658-60.
  10. Timaran CH, Mantese VA, Malas M, Brown OW, Lal BK, Moore WS et al. Differential outcomes of carotid stenting and endarterectomy performed exclusively by vascular surgeons in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). J Vasc Surg. 2013; 57 (2): 303-8.
  11. De Martino RR, Eldrup-Jorgensen J, Nolan BW, Stone DH, Adams J, Bertges DJ et al. Perioperative management with antiplatelet and statin medication is associated with reduced mor-tality following vascular surgery. Journal of Vascular Surgery. 2014; 59 (6): 1615-21.
  12. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association / American Stroke Association. Stroke. 2011; 42: 227-76.
  13. Parfenov VA. Faktory riska i vtorichnaja profilaktika ishemicheskogo insul'ta [Risk fac-tors and secondary prevention of ischemic stroke]. Nervnye bolezni [Neurological diseases]. 2007; 4 (1): 2-8. (in Russian)
  14. Fonjakin AV, Geraskina LA, Shan-dalin VA. Profilaktika serdechno-sosudistyh oslozhnenij posle ishemicheskogo insul'ta: standarty, dejstvitel'nost' i perspektivy [Prevention of cardiovascular complications after ischemic insult: standards, reality and prospects]. Nevrologija, nejropsihiatrija, psihosomatika [Neurology, neuropsychiatry, psychosomatics]. 2010; 1: 24-9. (in Russian)
  15. Hindler K, Shaw AD, Samuels J, Fulton S, Collard CD, Riedel B. Improved postopera-tive outcomes associated with preoperative statin therapy. Anesthesiology. 2006; 105: 1260-72.
  16. Gavrilenko AV, Ivanov VA, Piven' AV, Kuklin AV, Kravchenko AA, Miklashevich JeR et al. Rezul'taty karotidnoj jendarterjektomii i stentirovanija pri stenoze sonnyh arterij [The results of carotid endarterectomy and stenting stenosis of the dream-governmental arteries]. Angi-ologija i sosudistaja hirurgija [Angiology and vascular surgery]. 2012; 18 (1): 105-13. (in Russian)
  17. Ipatenko VT, Davydkin VI, Erzin MF, Piksin IN, Savrasova TV, Jahudina KR. Hirur-gicheskoe lechenie stenozirujushhih porazhenij sonnyh arterij [Surgical treatment of stenosing le-sions of carotid arteries]. Uspehi sovremennogo estestvoznanija [Successes of modern natural sci-ence]. 2014; 11 (2): 20-4. (in Russian)
  18. Demirel S, Attigah N, Bruijnen H, Ringleb P, Eckstein HH, Fraedrich G et al. Multicen-ter experience on eversion versus conventional carotid endarterectomy in symptomatic carotid ar-tery stenosis: observations from the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE-1). Stroke. 2012; 43 (7): 1865-71.
  19. Kucherenko SS. Karotidnaja jendarterjektomija i karotidnoe stentirovanie: za i protiv [Carotid endarterectomy and carotid stenting: for and against]. Vestnik rossijskoj voenno-medicinskoj akademii [Vestnik of Russian military medical Academy]. 2011; 35 (3): 220-5. (in Rus-sian)
  20. McGirt MJ, Perler BA, Brooke BS. 3-Hydroxy-3- methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg. 2005; 42: 829-36.
  21. Kosenkov AN, Vinogradov RA. In-farkt miokardposle karotidnoj jendarterjekto-mii [Myocardial infarction after carotid en-darterectomy]. Kardiologija i serdechno-so-sudistaja hi-rurgija [Cardiology and cardio-vascularsurgery]. 2015; 8 (6): 14-6.

版权所有 © Zybin A.V., Timina I.E., Pokrovsky A.V., Harazov A.F., 2017

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可
 


##common.cookie##